Elamipretide (SS-31) Tracker App
Track Your Elamipretide (SS-31) Protocol
Elamipretide (SS-31) is a mitochondrial peptide. Shotlee is the free app to track your Elamipretide (SS-31) protocol — log every dose, injection site, side effect, and health metric in one place.
What Is Elamipretide (SS-31)?
Elamipretide (SS-31) is a mitochondrial peptide. Shotlee is the free app to track your Elamipretide (SS-31) protocol — log every dose, injection site, side effect, and health metric in one place.
Shotlee tracks every aspect of your Elamipretide (SS-31) protocol: injection dates, doses, sites, side effects, weight changes, and lab results. Whether you are starting or optimizing, clean data makes better decisions.
What to Track in Shotlee
Build a complete Elamipretide (SS-31) protocol record from day one.
How to Track Your Elamipretide (SS-31) Protocol
Elamipretide (SS-31) Key Facts
Protocol FAQs
A mitochondria-targeting peptide that stabilizes cardiolipin to improve inner mitochondrial membrane integrity and electron transport efficiency. Studied for heart failure, mitochondrial disease, and longevity.
Clinical trials use 0.025–0.25mg/kg/day subcutaneously. Off-label longevity use typically involves 5–10mg/day SQ. Always under medical supervision.
Log each injection with dose and time. Track energy levels, exercise performance, and any cardiac function markers your physician monitors. Consistent logging over 4–12 weeks reveals your personal response.
Open the Shotlee app, navigate to the dose logging screen, select Elamipretide as your medication, and enter the dose amount, injection site, and time. Shotlee stores all entries with timestamps and lets you view your complete dose history, adherence rate, and missed dose alerts. The app is free to download and use.
The most important side effects to track include gastrointestinal symptoms (nausea, vomiting, diarrhea, constipation), injection site reactions, appetite changes, energy levels, and any unusual symptoms. Log these daily in Shotlee so you can share accurate trend data with your healthcare provider at your next visit.
Most patients begin noticing appetite changes within the first one to two weeks. Measurable weight loss typically becomes apparent by weeks four to eight, depending on the dose titration schedule and individual metabolic response. Track your weekly weight in Shotlee to visualize your personal response curve over time.
Track Your Elamipretide (SS-31) Protocol in Shotlee
Free dose logs, side effect tracking, weight trends, and lab results — all in one app.